Table 2.
Pre-conversion (n = 37) |
Six months following INHD conversion (n = 37) |
Twelve months following INHD conversion (n = 31) | |
---|---|---|---|
Reduction in urea, % | 71.7 ± 6.7 | 84.9 ± 6.3* | 86.7 ± 6.4* |
Hemoglobin, in g/L | 114.5 ± 17.3 | 119.1 ± 14.8 | 117.1 ± 13.5 |
Serum albumin, in g/L | 33.7 ± 3.5 | 33.3 ± 3.0 | 32.8 ± 4.4 |
Calcium, in mmol/L | 2.12 ± 0.23 | 2.20 ± 0.12* | 2.18 ± 0.17 |
Phosphate, in mmol/L | 2.10 ± 0.59 | 1.57 ± 0.49* | 1.46 ± 0.47* |
PTH, in pmol/L | 26 (20-41) | 28 (15-74) | 36 (17-61) |
ALP, in Units/L | 95 (63-138) | 124 (105-167)* | 144 (92-212)* |
Data are presented as means ± standard deviation or medians (interquartile range), as appropriate. The paired t-test was used to compare pre- and post-conversion differences for normally-distributed variables and the signed rank test was used for non-normally distributed variables.
* denotes p-value of < 0.05 for change in the laboratory value as compared to pre-conversion to INHD